CNS/Neurology Market Research Reports & Industry Analysis
A neurologist is a medical doctor that specializes in the diagnosis, treatment and management of illnesses affecting the brain, spinal cord, and nervous system. Neurologists must complete at least three years of specialized training in neurology, after completing medical school. A neurosurgeon must go through much more extensive and rigorous schooling and training. On top of diagnosing and treating neurological disorders, neurosurgeons can also perform surgery on the brain, spinal cord, and nerves.
Pharmaceuticals in CNS/Neurology are one of leading fields in medicine in terms of funding and research. On top of growing patient numbers, there remains a comparatively high unmet need in treatment of many neurological diseases. With the potential of being one of the most lucrative therapy areas in the future pharmaceutical Industry, Alzheimer's disease offers the greatest commercial opportunity for pharmaceutical companies in neurology. Many of the therapeutic drugs used to treat CNS/Neurological disorders have lost their patent protection or market exclusivity, leading to greater research and market opportunities for competing pharmaceutical and medical device companies. Despite the widespread use of CNS drugs, knowledge of these agents is limited due to the anatomic and neurochemical complexity of the brain and spinal cord.
CNS/Neurology Industry Research & Market Reports
-
Human Organoids Market by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), Disease Area (Oncology, GI, Neurological Disorders), Application (Drug Toxicity, Personalized Medicine), End User (Pharma & Biotech Companies, CROs) - Global Forecast to 2029
... value of the human organoids market will increase from an estimated USD 1.19 billion in 2024 to USD 2.33 billion in 2029, at a CAGR of 14.4% through the forecast period. Advancement in funding for ... Read More
-
Intracranial Aneurysms - Market Insights, Competitive Landscape, and Market Forecast - 2030
... America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing cases of chronic disorders and the rising product developmental activities worldwide The ... Read More
-
Deep Brain Stimulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
... Epilepsy, Obsessive Compulsive Disorder, Dystonia, and Others), End-User (Hospitals and Specialty Clinics), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing ... Read More
-
Major Depressive Disorder Market Assessment, By Drug Classes [Selective Serotonin Reuptake Inhibitors, Selective Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Others], By Distribution Channel [Hospital Pharmacies, Retail Pharmacies, Online Pharmacies], By Region, Opportunities and Forecast, 2017-2031F
... United States radiotherapy devices market is projected to witness a CAGR of 8.70% during the forecast period 2024-2031, growing from USD 2.56 billion in 2023 to USD 4.99 billion in 2031. The market growth is ... Read More
-
Electrical Stimulation Devices Global Market Opportunities And Strategies To 2033
... Neurological & Movement Disorder Management; Musculoskeletal Disorder Management; Metabolism & Git Management3) By End-User: Hospitals; Ambulatory Surgical Centers Covering: Medtronic plc; Boston Scientific Corporation; Abbott Laboratories; Koninklijke Philips N.V.; Nevro Corp Electrical Stimulation Devices Global ... Read More
-
Global Migraine Drugs Market - 2024-2031
... forecast period 2024-2031. Migraine is a headache characterized by recurrent attacks of moderate to severe throbbing and pulsating pain on one side of the head. These attacks are caused by nerve fiber activation within brain ... Read More
-
Global Acetylcholinesterase Inhibitors Market - 2024-2031
... forecast period 2024-2031. Acetylcholinesterase inhibitors (AChEIs) are a specific kind of drug that is essential in the treatment of a variety of neurological illnesses, including Alzheimer's disease and other forms of dementia. These medications work ... Read More
-
Antidepressant Market Report: Trends, Forecast and Competitive Analysis to 2030
... and panic disorder markets. The global antidepressant market is expected to reach an estimated $21.8 billion by 2030 with a CAGR of 5.3% from 2024 to 2030. The major drivers for this market are the ... Read More
-
2024 France Antipsychotic Drugs Forecast (2025-2030 Outlook)-Market Opportunities Report
... industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are ... Read More
-
2024 Japan Antipsychotic Drugs Forecast (2025-2030 Outlook)-Market Opportunities Report
... industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are ... Read More
-
2024 China Antipsychotic Drugs Forecast (2025-2030 Outlook)-Market Opportunities Report
... industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are ... Read More
-
2024 United States Antipsychotic Drugs Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 Global Antipsychotic Drugs Forecast (2025-2030 Outlook)-Market Opportunities Report
... industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are ... Read More
-
2024 Latin America Antipsychotic Drugs Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 Asia-Pacific Antipsychotic Drugs Forecast (2025-2030 Outlook)-Market Opportunities Report
... industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are ... Read More
-
2024 Europe Antipsychotic Drugs Forecast (2025-2030 Outlook)-Market Opportunities Report
... industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are ... Read More
-
2024 India Antipsychotic Drugs Forecast (2025-2030 Outlook)-Market Opportunities Report
... industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are ... Read More
-
2024 Germany Antipsychotic Drugs Forecast (2025-2030 Outlook)-Market Opportunities Report
... industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are ... Read More
-
2024 North America Antipsychotic Drugs Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 United Kingdom Antipsychotic Drugs Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
Conventional and Alternative Pain Treatment Markets
... and alternative pain treatments and includes a detailed analysis of the competitive environment. The report covers the drivers, restraints and opportunities in the market; surveys the prevalence of or incidence of chronic diseases; and highlights ... Read More
-
Global Brain Tumor Diagnostics Market 2024-2028
... period. The report on the brain tumor diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Cell and Gene Therapy Market Research Report Information by Therapy Type (Cell Therapy and Gene Therapy), Application (Cancer, Neurological Disorders, Cardiovascular Disorders, Rare Diseases, Ophthalmology, Blood Disorders and Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032
... and Rest of the World) Industry Forecast till 2032 In 2023, the e-Visa market was estimated to be worth USD 933.4 million. With a compound annual growth rate (CAGR) of 11.1% from 2024 to 2032, ... Read More
-
Schizophrenia - Pipeline Insight, 2024
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Schizophrenia: Understanding Schizophrenia: ... Read More
-
Brain Computer Interface
... by 2030, growing at a CAGR of 10.3% over the analysis period 2023-2030. Invasive BCI, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$1.5 Billion by ... Read More
Research Assistance
